Abogen Biosciences

Developer of mRNA-based therapeutics for cancer and infectious diseases

placeSuzhou, Jiangsu, China calendar_todayFounded 2019 language abogenbio.com

Innovation

6 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace active. Cited 121 times.

YearFilings
20243
20253

Investor mix

42 investors on record; lead investors include SoftBank Vision Fund, 5Y Capital, TF Capital, Yunfeng Capital.

Investor typeCountShare
Venture capital1945%
Private equity717%
Angel & family office12%
Bank & private debt12%
Other / undisclosed1433%
Coming soon